With continued investment in mRNA research, Donald Trump could turn the stalemate against cancer into a decisive breakthrough ...

Recently, antivaxxers have been expressing their impatience with HHS Secretary Robert F. Kennedy Jr.'s progress eliminating ...

According to Nova One Advisor, the global mRNA synthesis & manufacturing market size is calculated at USD 1.58 billion in 2025 and is expected to be hit around USD 1.87 billion by 2034, growing at a ...

Now, there’s a new player in town called CancerVax, and it’s getting a lot of attention. This article is going to look at ...

Moderna, Inc. (MRNA) is a biotechnology firm based in Cambridge, Massachusetts, that focuses on mRNA technology to create ...

The study was published in Nature Biotechnology last month and marks a shift in scientists’ understanding of how to ...

Researchers showed that an mRNA influenza vaccine delivered with their new lipid nanoparticle could generate the same immune ...

The story of the pharmaceutical company Moderna almost reads like a Hollywood screenplay. In its relatively short life, it ...

There’s some really interesting news coming out of the cancer research world lately, specifically about something called ...

The U.S. government is turning its back on a medical breakthrough that has saved millions of lives, halting $500 million in ...

In this week's STATus Report, STAT reporters Jason Mast and Damian Garde discuss the challenges facing Moderna — and what could be in store for its third act.